The majority of ETB work involves collaborations with disease-focused laboratories across the globe. Through an active outreach program, the ETB is continually building new research partnerships. Collaborators work with ETB scientists to develop screens against promising drug targets and to refine these results into small molecule probes and potential therapies.
Close communication between external investigators and ETB staff enables the terms of these strong collaborations to remain flexible and specific to each project. These partnerships provide unique resources to both parties and help disseminate high-quality small molecules and cutting-edge knowledge to the broader research community. Learn more about the ETB in action.